Asenapine HCl inhibits the signaling pathway between G-protein-coupled receptors (GPCRs) and G proteins. It targets 5-HT2A receptor, 5-HT2C receptor, 5-HT7 receptor, D2 receptor, D3 receptor, D4 receptor, and sPLA2.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.